Bridging Gaps in Indian Cancer Care: A Conversation with Nivedita Basu, Founder of Global Cancer Care

An Exclusive Interview with Nivedita Basu, Founder of Global Cancer Care, a non-profit organization dedicated to cancer awareness, prevention, and palliative care

In this interview, Nivedita Basu, Founder of Global Cancer Care, shares her inspiring shift from media leadership to healthcare entrepreneurship. She unveils the vision for early detection and patient navigation in India, highlighting evolving ecosystem changes.

​You’ve had a long and influential career shaping India’s television and OTT content. What inspired your shift from entertainment to building a healthcare-focused platform like Global Cancer Care?

Nivedita Basu: For the past 25 years, I’ve built and shaped multiple brands from defining television genres like saas-bahu storytelling, to running three startup OTT platforms, and even spending time in hospitality.

Across industries, my approach has always been the same: if I commit to something, I do it with complete conviction and the intent to do my best.

Over time, I realised that the skills I had built storytelling, scale, credibility, and audience connection could be applied to something far more urgent.

I’ve taken a lot from society in terms of opportunities, visibility, and trust, and at some point it felt important to give back in a way that genuinely matters.

Having some of the best oncologists as friends and collaborators, and seeing the gaps they deal with daily, made healthcare feel like a natural next step rather than a sudden shift.

Global Cancer Care was born from that conviction to apply everything I know to a space where impact goes far beyond content.

How did your personal health scare influence the vision and purpose behind GCC?

Nivedita Basu: In mid-2025, I went for a regular health check-up not because I felt unwell, but because suddenly there were far too many people around me being diagnosed at advanced stages.

Stage three seemed to be coming up far too often, and it unsettled me. I went alone, quietly, without family or a driver just a rickshaw ride thinking this was routine, something we all should be doing anyway.

What I didn’t expect was what followed. During one of the final marker tests, doctors detected a lump something I physically could not feel at all during self-examination. My body had given me no warning signs, which made the discovery even more frightening.

What followed were hours and days of waiting, uncertainty, and fear. The hardest part wasn’t pain or symptoms it was the absence of clarity. No immediate answers, no clear roadmap, just time stretching endlessly.

That experience changed my perspective completely. It made me realise that early detection doesn’t always come from symptoms and that the real trauma often isn’t the diagnosis itself, but the waiting without guidance. That realisation became foundational to GCC.

When you first began thinking of Global Cancer Care, what specific gaps in India’s early detection and patient navigation ecosystem stood out to you?

Nivedita Basu: Three gaps became very clear very quickly. First, early detection is delayed because of fear, stigma, and the belief that “if I can’t feel anything, I must be fine.” Second, there is almost no structured patient navigation people move between labs, doctors, opinions, and hospitals without clarity.

Third, communication around cancer is often cold, technical, or intimidating. India doesn’t lack doctors or hospitals. It lacks guidance, continuity, and compassion, especially at the earliest stages where intervention can make the biggest difference.

Transitioning from media leadership to healthcare entrepreneurship is a significant shift. What were the biggest mindset and operational changes you had to make?

Nivedita Basu: In media, speed and scale drive everything. In healthcare, responsibility and accuracy come first. I had to slow down, listen deeply, and build with humility. This space doesn’t allow shortcuts or disruption for disruption’s sake.

Every decision affects real lives. Operationally, it meant moving from instinct-led decision-making to evidence-based systems, clinical validation, and long-term thinking. The stakes are far higher, and that fundamentally changes how you build.

How did you translate your storytelling and content strategy experience into creating a guidance-focused, patient-first support platform?

Nivedita Basu: Storytelling isn’t about drama it’s about making complexity human. Cancer information is often overwhelming and frightening. GCC uses storytelling to simplify conversations, reduce fear, and encourage early action without alarm.

We don’t speak at people; we guide them step by step. For us, content isn’t marketing. It’s navigation. When people understand what’s happening and what to do next, fear reduces and action follows.

What challenges did you face while building GCC from the ground up whether credibility, partnerships, structure, or public awareness?

Nivedita Basu: Credibility was the first hurdle. Coming from media, I had to earn trust carefully by working closely with respected oncologists, building ethical partnerships, and never over-promising outcomes.

Public awareness was another challenge. Cancer is a word people avoid. A big part of our work has been shifting the conversation from fear and stigma to empowerment and routine screening.

Structurally, healthcare demands patience. Compliance, partnerships, and processes take time. But cutting corners was never an option.

As an entrepreneur, how do you plan to scale GCC across metros and ensure it remains both compassionate and operationally strong?

Nivedita Basu: Scale without empathy is dangerous, especially in healthcare. Our focus is on strong systems supported by local clinical partnerships, not rushed expansion.

Technology will help us scale efficiently, but human guidance will always remain central. GCC will never be a faceless service. It will always be a guide calm, credible, and compassionate.

Looking ahead to 2026, what key trends do you foresee in India’s early cancer detection and patient support landscape, and where do you see GCC’s role in that transformation?

Nivedita Basu: By 2026, I see early cancer detection becoming more non-invasive, more routine, and more openly discussed. Preventive healthcare will enter mainstream conversations, and patients will demand clarity, transparency, and dignity not fear-driven decisions.

A big part of this shift will be driven by media, social platforms, and influencers. Today, nothing gains momentum unless it enters people’s feeds.

Once early screening and awareness start appearing organically on social media, resistance reduces and curiosity increases. Even that first step is half the battle won.

But for this to truly scale, it cannot be done alone. The long-term vision for GCC is to actively involve corporates, institutions, and eventually the government, so that it’s not limited to one part of Mumbai but becomes a nationwide support system across India.

My eventual dream is to build GCC centres with cashless systems and no billing counters where a person walks in, gets screened or guided, and walks out without worrying about money, paperwork, or affordability. No fear-inducing queues. No anxiety around cost.

If I’m able to create a system where care is delivered with dignity and without the question, “How much will this cost me?” then I will truly feel I’ve achieved what I set out to do.

That, for me, would be real success not just as an entrepreneur, but as Nivedita Basu, someone who used everything she learned over 25 years to give something meaningful back to society.

Nivedita Basu’s journey underscores Global Cancer Care’s pivotal role in cancer awareness and palliative support. Her insights on early detection and ecosystem evolution inspire hope, urging collective action for better patient outcomes in India.

Read more Success stories of Indian entrepreneurs, Women Entrepreneurs & startups stories at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn